Avner Schneur has led several companies from the early stage to IPO or other exits. Avner Schneur is the President and CEO of GRM a leading Record and Document Management company www.grmdocumentmanagement.com Under Schneur’s leadership, GRM accelerated its growth, expanded its digital offering, and extended operations geographically beyond the US to South America - Peru, Brazil, and Colombia.
Schneur is the President and CEO of VisualVault, a leading cloud-native content platform. www.visualvault.com.
Schneur is the Founder and CEO of Kormeli, LLC www.kormeli.com an investment group dedicated to funding and guiding early-stage technology entrepreneurs and enterprises.
Schneur is the chairman of Petpace www.Petpace.com and Zappix www.Zappix.com. Schneur was the Chairman of InfiniteMD, which was sold to ConsumerMedical, which was then sold to Alight. He was also a Board member of Nipendo www.nipendo.com which was sold to Amex. Other recent exits include True Clinic, which was sold to Intouch, which was then sold to Teledoc.
In late 1999 Schneur founded Emptoris Inc, a leading Supply and Contract Management Software company, and served as the company’s Chairman, President and CEO. Schneur’s goal was to transform the way companies procure goods and services utilizing mathematical optimization technology. The company’s novel approach involved taking a broader look at the total cost of major procurements, ultimately enabling substantial savings for customers. Emptoris was acquired by IBM in 2011.
Before founding, Emptoris Schneur held a number of executive positions at Vectis Corporation - a leading software vendor of electronic medical records, Astea International - a leading developer of customer interaction software where helped lead the company to a successful IPO, and Elscint, Inc. - a manufacturer of high-end medical imaging systems.
Schneur Graduated Cum Laude from the Technion’s (Israel Institute of Technology) Industrial Engineering department, with a specialty in Information Systems. Schneur is a member of the Technion Industrial Engineering Faculty Advisory Board.
Schneur and his wife, Rina, established the The Rina and Avner Schneur Center of Type II Diabetes Research. The center brings together top researchers from the faculty of Biomedical Engineering and the faculty of Medicine at the Technion Israel Institute of Technology to seek a cure to type II diabetes.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.